Marker therapeutics, inc. (MRKR)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Total revenues

-

-

0

0

-

-

0

205

-

-

183

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign exchange translation adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

55

2

1

-1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL COMPREHENSIVE LOSS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,564

754

-29,708

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development - intellectual property acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Management fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

62

-

-

-

-

-

-

-

-

-

-

-

-

Interest and finance charges (Note 4)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-291

-

-

-

-

-

-

-

-

-

-

-

Management fees (Note 8)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-58

-

-

-

-

-

-

-

-

-

-

-

Management fees - stock-based (Notes 8 and 9)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11

-

-

-

-

-

-

-

-

-

-

-

Interest and financing charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

334

-

-

-

-

-

-

-

-

-

-

Interest and finance charges (Note 4)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

214

100

-

-

103

-

-

-

-

Interest and financing charges (Note 4)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

96

-

-

-

-

-

-

Management fees (Note 8)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

58

177

22

22

80

62

62

62

62

54

74

Management fees - stock-based (Note 8)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15

-

-

-

-

-

-

-

-

-

-

Management fees - stock-based (Notes 8 and 9)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-22

31

86

29

-

29

-

-

-

-

Professional fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

69

118

266

280

21

112

74

120

36

164

116

170

278

Research and development

3,816

3,661

3,118

3,152

2,832

2,649

1,877

1,826

1,599

1,435

1,623

1,202

989

456

1,109

1,248

985

-68

968

201

609

111

32

22

22

478

30

54

134

625

71

245

115

-203

297

57

51

93

106

Consulting fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

57

36

-

-

-

-

-

-

-

-

-

-

-

Consulting fees - stock-based (Note 9)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15

-

-

-

-

-

-

-

-

-

-

-

Consulting

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30

-

-

-

0

-

-

-

-

-

-

Consulting - stock-based (Note 9)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

67

-

-

-

133

-

-

-

-

-

-

Consulting fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

57

62

-

60

43

25

50

28

26

Consulting fees  stock-based (Note 9)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

109

2,039

-

-

307

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

0

0

-

-

-

General and administrative

2,826

1,914

2,536

2,721

2,805

17,177

2,551

3,052

1,597

1,244

2,549

1,190

1,427

1,134

1,612

1,177

767

2,322

769

936

418

178

1,351

488

1,164

1,600

70

88

207

133

268

468

141

239

23

37

5

32

94

Total operating expenses

6,643

5,575

5,654

5,873

5,638

135,871

4,428

4,879

3,197

2,680

4,172

2,393

2,416

1,591

2,721

2,425

1,753

-

-

-

-

-

1,383

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

796

3,138

-

-

-

-

-

-

-

Stock based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

256

458

-

-

Costs and Expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

701

1,100

1,233

1,282

Loss from operations

-6,643

-5,362

-5,654

-5,873

-5,638

-135,871

-4,428

-4,673

-3,197

-2,680

-3,989

-2,393

-2,416

-1,591

-2,721

-2,425

-1,753

-2,254

-1,737

-1,138

-1,028

-

-

-

-

-

-

-

-

-

-796

-3,138

-671

-

-

-701

-1,100

-1,233

-1,282

Loss from Operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,383

-510

-1,186

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expense):
Accretion of interest on convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liabilities

31

98

-64

-7

-9

58

40

-139

1

-3

4

7

-3

14

684

8,237

-2,996

613

30,266

-59,079

327

60

-74

352

-338

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grant income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign exchange gain

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

0

0

-6

12

-10

-7

17

-7

-

-

-6

-8

-2

2

Grant income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

231

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest and financing charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15

-

-

-

-

-

-

-

-

-

-

-

-

98

356

458

170

Accretion of discount on convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-483

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest and financing charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

35

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in fair value of derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

266

781

-

-

-

-

-

-

-

-

-

-

-

Total Expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

904

-

-

-

-

NET LOSS BEFORE OTHER ITEMS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-904

-

-

-

-

Foreign exchange (loss) gain

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14

-

-

-

-

Changes in fair value of derivative liabilities (Note 4)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,097

-315

121

352

71

1,085

46

-217

-244

191

1,532

Accretion of discount on convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

646

-

0

-

-

-

-

-

-

-

-

-

-

Loss on lawsuit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Accretion of interest on convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Loss on debt financing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-85

0

-

-

-

-

-

-

-

Loss on debt settlement agreements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-65

-70

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-1,615

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign exchange

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain (loss) on settlement of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-94

920

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on debt financing (Note 5)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Loss on settlement of debt (Notes 5 and 9)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-436

-

-

-

-

-

-

-

-

-

-

Loss on debt financing (Note 5)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

Loss on lawsuit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Interest and finance charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-22

-

-

-

-

-

-

-

-

-

-

-

-

Loss on debt financing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-104

-96

-

-

-

-

-

-

-

-

-

-

-

Loss on settlement of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-168

-874

-

-

-

-

-

-

-

-

-

-

-

Gain on extinguishment of derivative liabilities - warrants (Note 4)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

396

290

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

-

-

-

-

-

Gain (loss) on settlement of debt (Note 8)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Gain on extinguishment of derivative liabilities - warrants (Note 5)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Interest income

126

184

259

310

328

253

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

Debt extinguishment gain

-

-

-

-

-

-

-

-

-

-

0

492

-

-

0

0

-

-

-24

-

-

-

-

-

-27,663

-

-

0

0

-

0

18

9

-

-

125

-204

30

23

Loss on disposal of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

0

0

-

-

-

Net loss

-6,485

-5,079

-5,459

-5,570

-5,318

-135,560

-4,388

-4,812

-3,196

-2,683

-3,985

-1,893

-2,419

-1,576

-2,102

5,974

-4,749

-1,652

28,503

-60,216

-700

-361

-1,567

753

-29,707

-3,475

-744

-870

-441

-

-

-

-598

-

-

-404

-1,267

-1,014

-1,339

Total Expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

290

675

-

-

-

-

-

-

-

-

-

-

-

Research and development - stock-based

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-

0

-

-

-

-

TOTAL COMPREHENSIVE LOSS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-290

-675

-1,115

-

-

-

-

-

-

-

-

-

-

Foreign exchange translation adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-1

4

-1

-

-

-

-

-

-

-

-

-

-

TOTAL COMPREHENSIVE LOSS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,252

-967

-866

-442

-

-

-

-

-

-

-

-

-

-

Net Loss for the Period

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-768

-2,750

-

-

-844

-

-

-

-

Net loss per share, basic and diluted

-0.14

-0.11

-0.12

-0.12

-0.12

-6.72

-0.32

-0.41

-0.30

-0.26

-0.39

-0.22

-0.29

-

-

-

-0.81

-

-

-

-0.03

-

-

0.05

-3.89

-2.69

-0.76

-0.87

-0.55

-9.36

-0.01

-0.04

-0.01

-

-

-0.01

-0.03

-0.03

-0.03

Weighted average number of common shares outstanding

46,084

45,728

45,655

45,501

45,465

40,173

13,733

11,838

10,622

10,588

10,219

8,576

8,429

-

-

-

5,882

-

-

-

27,611

-

-

15,523

7,631

1,470

1,266

1,000

806

-

-

-

52,470

-

-

46,676

-

-

-

Basic net loss per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.29

1.01

-

-

7.04

-1.80

-

-

-0.09

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted net loss per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.29

0.35

-

-

4.23

-1.80

-

-

-0.09

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average number of common shares outstanding, basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,281

5,935

-

-

4,048

33,525

-

-

17,310

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and Diluted Net Loss per Share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

-

-

-

-

Weighted average number of common shares outstanding, diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,281

6,524

-

-

6,745

33,525

-

-

17,310

-

-

-

-

-

-

-

-

-

-

-

47,213

-

-

-

-

Weighted Average Number of Common Shares Outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

73,128

61,966

-

-

-

-

-

-

-

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,572

40,042

39,826

Grant income
Total revenues

-

-

0

0

-

-

0

205

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-